The Mayo Clinic and University of Illinois Develop New Sensor for Detecting Methylated DNA
Researchers at both organizations created the new, single molecule test
The researchers believe this sensor test has potential in speeding up disease-specific analyses of genetic samples. George Vasmatzis, Ph.D., co-leader of Mayo’s Biomarker Discovery Program in the Center for Individualized Medicine, notes in the release that the assay could eliminate the need for bisulfite conversion of DNA, fluorescent labeling, and polymerase chain reaction (PCR). This research was done through the Mayo Illinois Alliance for Technology Based Healthcare, created in 2010 to advance research and clinical treatment options.
Subscribe to our mailing list, and we'll keep you posted of the latest developments.